Methylergonovine Maleate Tablets
Major Pharmaceuticals is recalling 0.2 mg Methylergonovine Maleate Tablets due to subpotency.
Contact your healthcare provider or pharmacist to discuss alternative treatment options and return the affected medication to the place of purchase.
Recall at a glance
- Quantity recalled
- 790 Cartons.
Why it was recalled
Major Pharmaceuticals is recalling Methylergonovine Maleate Tablets, 0.2 mg, due to the product being subpotent. This recall affects the 20-tablet carton configuration.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP
- Lot code
- N02327, 2026
- Strength
- 0.2 mg
- NDC / UPC
- NDC 0904-7282-10
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Drug Potency recalls
Other recent recalls from The Harvard Drug Group LLC
Editorial summary by Recall Canary · summary updated 2026-06-23 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification